Ascentage Pharma: Plans Share Buyback of ¥500–700 Million at ≤¥246/share, ~2.03–2.85 Million Shares
ChemoCentryx: Plans to repurchase shares for no less than RMB 500 million and up to RMB 700 million at a price not exceeding RMB 246 per share,预计 repurchasing 2.0325 million to 2.8455 million shares,
VolFlash analysisQueued
This event is in the analysis queue — usually done within 40s. Refresh to see it.
One email a day — don't miss the big ones
The 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.
Related events
Published：2026-11-04 20:27:34 · Source：wallstcn · Automatically aggregated and analysed — verify against the original source.